BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22753097)

  • 1. Immune thrombocytopenia: pathophysiologic and clinical update.
    Stasi R
    Semin Thromb Hemost; 2012 Jul; 38(5):454-62. PubMed ID: 22753097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
    Nugent D; McMillan R; Nichol JL; Slichter SJ
    Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Other immune thrombocytopenias.
    Liebman H
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S24-34. PubMed ID: 18096469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates in patients with elevated platelet-associated immunoglobulins.
    Szal M; Blumberg N
    Ann Clin Lab Sci; 1988; 18(1):24-33. PubMed ID: 3355094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietic agents in immune thrombocytopenia.
    Ghanima W; Bussel JB
    Semin Hematol; 2010 Jul; 47(3):258-65. PubMed ID: 20620437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE).
    Fabris F; Scandellari R; Randi ML; Carraro G; Luzzatto G; Girolami A
    Haematologica; 2002 Oct; 87(10):1046-52. PubMed ID: 12368159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of chronic immune thrombocytopenic purpura.
    Cines DB; McMillan R
    Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders.
    Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A
    Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.
    Cooper N; Stasi R; Cunningham-Rundles S; Cesarman E; McFarland JG; Bussel JB
    Br J Haematol; 2012 Aug; 158(4):539-47. PubMed ID: 22775462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
    McMillan R
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet IgG: measurement, interpretation, and clinical significance.
    George JN
    Prog Hemost Thromb; 1991; 10():97-126. PubMed ID: 2008535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in understanding the pathogenesis of immune thrombocytopenia.
    Semple JW; Provan D; Garvey MB; Freedman J
    Curr Opin Hematol; 2010 Nov; 17(6):590-5. PubMed ID: 20739879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia.
    Hu Y; Li H; Zhang L; Shan B; Xu X; Li H; Liu X; Xu S; Yu S; Ma D; Peng J; Hou M
    Hum Immunol; 2012 Jun; 73(6):629-35. PubMed ID: 22537755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PTPN22 gene polymorphism in childhood immune thrombocytopenic purpura.
    Anis SK; Abdel Ghany EA; Mostafa NO; Ali AA
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):521-5. PubMed ID: 21597364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dysmegakaryocytopoiesis and thrombopoiesis in autoimmune thrombocytopenias].
    Bellucci S
    C R Seances Soc Biol Fil; 1996; 190(5-6):541-8. PubMed ID: 9074719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
    Gernsheimer T
    Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell death in immune thrombocytopenia: novel insights and perspectives.
    von Gunten S; Wehrli M; Simon HU
    Semin Hematol; 2013 Jan; 50 Suppl 1():S109-15. PubMed ID: 23664507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.